Jens Eckstein

Dr. Eckstein is president of SR One in Cambridge, MA, USA. Prior to joining SR One, he was a Venture Partner at TVM Capital, Entrepreneur-in-Residence and appointed CEO and President of SelectX Pharmaceuticals. Prior to that, he was a General Partner in TVMs Boston life sciences practice where he focused on earlier-stage investments. He is the Chairman of the Board of Directors for Thrasos Therapeutics. He was a member of the Board of Directors for CoNCERT Pharmaceuticals, Enanta Pharmaceuticals, SelectX Pharmaceuticals, Rapid Micro Biosystems, Anchor Therapeutics, and an Advisor to Sirtris Pharmaceuticals. Prior to joining TVM Capital, Jens led drug discovery programs at Enanta Pharmaceuticals, Inc. and Mitotix, Inc. Jens is a Kauffman Fellow.